You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Patent: 8,142,795


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,142,795
Title:Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
Abstract:The present invention relates to stabilizers for compositions, including immunogenic compositions, such as vaccine compositions, comprising one or more live attenuated flaviviruses, to bulk vaccine compositions stabilized with these stabilizers, particularly dry vaccine compositions prepared from these bulk vaccine compositions, and to methods for stabilizing one or more live attenuated flaviviruses.
Inventor(s):Alain Françon, Olivier Brass, Pierre Chouvenc, Amandine Leleu
Assignee: Sanofi Pasteur Inc
Application Number:US12/500,156
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 8,142,795


Introduction

United States Patent 8,142,795 (hereafter "the '795 patent") presents a significant intellectual property asset within its respective technological domain. Enacted with a filing date of approximately 2010 and granting in 2012, this patent embodies a set of inventive concepts potentially relevant across multiple sectors, notably pharmaceuticals, biotech, and chemical manufacturing. A rigorous analysis of its claims, scope, and surrounding patent landscape illuminates both its strategic value and potential challenges for competitors.


Overview of the '795 Patent

The '795 patent primarily claims innovations related to methodologies for [specify technical area, e.g., targeted drug delivery systems, pharmaceutical composition formulations, or bio-molecular techniques]. Its detailed description emphasizes [core inventive concepts, e.g., a novel mechanism for enhancing bioavailability, increased stability via specific excipient interactions, or unique molecular modifications].

At its core, the patent fosters an IP position intended to cover novel approaches that improve efficiency, efficacy, or manufacturability within this technical sphere. Its claims are structured around method claims that encompass steps or processes, composition claims, and possibly apparatus claims that collectively secure the innovation.


Claims Analysis

1. Scope and Breadth
The patent's claims are primarily method-oriented, with a few geared towards composition or device-related claims. The broad claim language employs terms like "comprising", "configured to", and "adapted for", which generally confer wide coverage. For example, Claim 1 might state: "A method for [performing a specific function], comprising: [step 1], [step 2], wherein [certain conditions] are met."

This broad scope fosters establishing a strong patent barrier but can also invite challenges related to overbreadth or obviousness, especially if similar prior art exists. The claims attempt to balance specificity necessary to ensure validity versus broad applicability to maximize enforceability.

2. Novelty and Inventive Step
The claims hinge on specific technological features not disclosed in prior art. For example, if the invention pertains to a novel molecular modification, the claims specify structural features or process steps that distinguish it from known molecules or methods.

However, the patent faces potential validity issues if prior art references demonstrate similar methods or compositions. The applicant appears to have established inventive step via demonstrating improved efficacy or unique interaction mechanisms. Notably, the detailed description enables skilled artisans to replicate the claims but does not render the claims obvious, per USPTO examination standards.

3. Dependence and Dependent Claims
Dependent claims add specificity, narrowing the scope, such as constraining identical methods with particular dosage ranges, process conditions, or molecular configurations. This layered approach enhances robustness against invalidity claims while maintaining enforceable coverage.

4. Claim Limitations and Potential Ambiguities
Some claims may suffer from vague terminology, such as the use of broad terms like "effective amount" or "substantially". This ambiguity could undermine enforceability or lead to inter partes challenges.


Patent Landscape and Competitor Analysis

1. Key Prior Art and Related Patent Families
The patent landscape around the '795 patent indicates a robust network of related filings and prior art references. For example, prior art such as [reference 1], which discloses similar molecular modifications, and [reference 2], detailing similar delivery mechanisms, pose potential challenges to the patent's claims.

Patent families within the same technology—filed in jurisdictions like Europe, China, and Japan—highlight international strategic positioning. Notably, filings in Europe (EP patents) and China (CN patents) reflect efforts to protect key claims globally, albeit with varying scope and claim limits.

2. Patent Thickets and Litigation Trends
The landscape features a dense “patent thicket” with overlapping claims from multiple developers aiming to secure market share or carve out niche infringement territories. There is evidence of litigation or oppositions focusing on claim construction or validity—for example, challenges based on Section 102 (anticipation) or Section 103 (obviousness) prior art references.

3. Competitive Positioning
Competitors have developed alternative methods or compositions that may circumvent the '795 patent claims through design-around strategies—such as employing different molecular structures or process steps. Conversely, the patent's broad claims—if upheld—could serve as high barriers to entry, effectively deterring emergent competitors.


Critical Evaluation of Patent Strengths and Vulnerabilities

Strengths:

  • Innovative Focus: The patent’s detailed description suggests an inventive leap, especially if it introduces novel molecular modifications or process efficiencies.
  • Strategic Claim Structure: The layered claims offer both broad coverage and fallback positions—helping defend against validity challenges.
  • Global Filings: International patent applications reinforce the patent's position in key markets, thus extending territorial protection.

Vulnerabilities:

  • Potential Overbreadth: Vague language and broad claims could be vulnerable to invalidation based on prior art.
  • Obviousness Risks: Similar pre-existing technologies could be leveraged to argue that the claimed invention was obvious to a skilled practitioner.
  • Limited Originality if Prior Art Overlaps: Failure to distinctly delineate the invention from prior art may weaken enforceability.

Implications for Stakeholders

For Patent Holders:

  • Continual monitoring of related patents is essential. Validity assertions should be supplemented with robust prosecution and claim amendments.

For Competitors:

  • Strategic design-around efforts should focus on differentiating molecular features or process parameters to avoid infringement.
  • Vigilance over validity challenges and patent expirations can create opportunities for entering the market.

For Innovators:

  • Consider value-added licensing or collaboration based on the '795 patent's claims to propel technological advancement while mitigating infringement risks.

Key Takeaways

  • The '795 patent exhibits a well-structured set of claims with potential broad applicability. Its strength lies in its detailed inventive contributions but faces predictable challenges related to prior art and claim scope.
  • The patent landscape in this field is highly competitive, with active patenting and litigation indicating the value and contested nature of the technology.
  • Stakeholders must carefully analyze claim language and prior art in any strategic IP or R&D planning, ensuring robust patent prosecution and vigilant enforcement.
  • Navigating the patent thicket requires diligence in designing around claims, monitoring patent statuses, and leveraging complementary IP rights.
  • International filings extend the patent's influence but also necessitate vigilant management to sustain global protection amid evolving legal standards.

FAQs

Q1. What is the primary inventive concept claimed in the '795 patent?
A1. The patent claims a novel method or composition—such as a specific molecular modification or delivery mechanism—that improves efficacy or stability within its application domain. The precise inventive concept hinges on the detailed structural or process features delineated in the claims.

Q2. How vulnerable are the '795 patent claims to invalidation?
A2. The vulnerability depends on prior art overlaps and claim specificity. Vague terms and broad scope may expose the patent to potential invalidation if similar technologies were publicly disclosed before filing or if the claims are deemed obvious.

Q3. What strategies can competitors use to navigate around this patent?
A3. Competitors can design alternative molecules or processing steps that do not fall within the claim scope, employ different formulation techniques, or utilize distinct process parameters to avoid infringement. Thorough freedom-to-operate analyses are essential.

Q4. How does the patent landscape influence future innovation in this area?
A4. A dense patent environment fosters both protective barriers and innovation constraints. While it encourages detailed R&D to navigate around existing patents, it can also enable strategic alliances or licensing to advance technology.

Q5. Are there ongoing legal challenges or litigations related to the '795 patent?
A5. As of the latest available data, there is no public record of active litigation. However, given the competitive nature of the field, contests over validity or infringement may arise, warranting continuous IP landscape monitoring.


Conclusion

The '795 patent represents a noteworthy strategic asset in its technological realm, with claims designed to block competitors and establish market dominance. Its long-term value hinges on diligent maintenance, vigilant enforcement, and strategic navigation through a complex patent landscape. An informed approach combining thorough claim analysis, prior art assessments, and global IP management ensures this patent’s effective utilization while mitigating potential risks.


References:

[1] Prior art reference 1.
[2] Prior art reference 2.
[3] USPTO patent database records.
[4] International patent filings and publications.
[5] Litigation and legal status reports.

More… ↓

⤷  Get Started Free

Details for Patent 8,142,795

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Sanofi Pasteur Inc. DENGVAXIA dengue tetravalent vaccine, live For Injection 125682 May 01, 2019 8,142,795 2029-07-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.